HACT Achieves Major Milestone with Dual Registration in USA and Ethiopia
Horn of African Clinical Trials (HACT) has been officially registered as a C-Corporation in Delaware, USA, and has begun formal registration in Ethiopia, strengthening its legal foundation and commitment to advancing clinical research capacity across the region.
HACT has reached a significant milestone in its organizational development with successful registration as a C-Corporation in Delaware, USA, and initiation of formal registration processes in Ethiopia. This dual registration strengthens HACT's legal foundation and demonstrates its commitment to operating with the highest standards of corporate governance across both jurisdictions. The registration enables HACT to expand its partnerships, secure funding, and deliver on its mission to build ethical clinical research capacity in the Horn of Africa region.